JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web browser. It makes web pages functional for specific purposes and if disabled for some reason, the content or the functionality of the web page can be limited or unavailable.

Monday, March 17, 2025

CDC estimates 3 in 4 kids have had coronavirus infections

by

1054 days ago
20220427
FILE - Boxes of KN95 protective masks are stacked together before being distributed to students at Camden High School in Camden, N.J., Wednesday, Feb. 9, 2022. According to a study by the Centers for Disease Control and Prevention released Tuesday, April 26, 2022, three out of every four U.S. children have been infected with COVID-19. (AP Photo/Matt Rourke, File)

FILE - Boxes of KN95 protective masks are stacked together before being distributed to students at Camden High School in Camden, N.J., Wednesday, Feb. 9, 2022. According to a study by the Centers for Disease Control and Prevention released Tuesday, April 26, 2022, three out of every four U.S. children have been infected with COVID-19. (AP Photo/Matt Rourke, File)

By MIKE STO­BBE-As­so­ci­at­ed Press

 

NEW YORK (AP) — Three out of every four U.S. chil­dren have been in­fect­ed with the coro­n­avirus and more than half of all Amer­i­cans had signs of pre­vi­ous in­fec­tions, Cen­ters for Dis­ease Con­trol and Pre­ven­tion re­searchers es­ti­mat­ed in a re­port Tues­day.

The re­searchers ex­am­ined blood sam­ples from more than 200,000 Amer­i­cans and looked for virus-fight­ing an­ti­bod­ies made from in­fec­tions, not vac­cines. They found that signs of past in­fec­tion rose dra­mat­i­cal­ly be­tween De­cem­ber and Feb­ru­ary, when the more con­ta­gious omi­cron vari­ant surged through the U.S.

For Amer­i­cans of all ages, about 34% had signs of pri­or in­fec­tion in De­cem­ber. Just two months lat­er, 58% did.

“I did ex­pect it to in­crease. I did not ex­pect it to in­crease quite this much,” said Dr. Kristie Clarke, co-leader of a CDC team that tracks the ex­tent of coro­n­avirus in­fec­tions.

The news came as Pfiz­er sought per­mis­sion to of­fer a boost­er dose to kids ages 5 to 11, just like peo­ple 12 and old­er can get.

In the CDC re­port, the most strik­ing in­crease was in chil­dren. The per­cent­age of those 17 and un­der with an­ti­bod­ies rose from about 45% in De­cem­ber to about 75% in Feb­ru­ary.

The old­er peo­ple were, the less like­ly they had ev­i­dence of past in­fec­tions. That may be be­cause old­er adults have high­er vac­ci­na­tion rates and they may be more like­ly to take oth­er COVID-19 pre­cau­tions, such as wear­ing masks and avoid­ing crowds, Clarke said.

Re­port­ed COVID-19 cas­es had a huge surge in De­cem­ber and Jan­u­ary, then fell al­most as dra­mat­i­cal­ly as they had risen. But dai­ly case counts have been trend­ing up again in re­cent weeks.

The case num­bers are be­lieved to be an un­der­count, but of­fi­cials do think re­cent in­creas­es re­flect a true rise in in­fec­tions. Many COVID-19 in­fec­tions are mild enough that pa­tients do not seek care or con­fir­ma­to­ry lab tests. CDC of­fi­cials say they plan to re­lease a study soon that es­ti­mates that in re­cent months there were three in­fec­tions for every re­port­ed case.

An­oth­er re­cent trend: U.S. health of­fi­cials say they have seen two weeks of in­creas­es in COVID-19 hos­pi­tal­iza­tions, though the num­bers re­main rel­a­tive­ly low. Hos­pi­tal ad­mis­sions num­ber about 1,600 per day, a 9% in­crease in the pri­or week, the CDC re­port­ed.

Avail­able ev­i­dence nev­er­the­less of­fers rea­son to be hope­ful about how the pan­dem­ic is go­ing, of­fi­cials sug­gest­ed.

“We are not an­tic­i­pat­ing more se­vere dis­ease from some of these sub­vari­ants, but we are ac­tive­ly study­ing them,” CDC Di­rec­tor Dr. Rochelle Walen­sky said Tues­day.

The tests that showed how many peo­ple had pre­vi­ous in­fec­tions can de­tect an­ti­bod­ies for one to two years af­ter in­fec­tion, and pos­si­bly longer. Stud­ies have shown pre­vi­ous in­fec­tion can pro­tect some peo­ple against se­vere dis­ease and hos­pi­tal­iza­tion, but CDC of­fi­cials stressed that the pre­vi­ous­ly in­fect­ed should still get COVID-19 vac­cines.

The study looked for any de­tectable lev­el of an­ti­bod­ies; it did not dis­tin­guish how many peo­ple had an­ti­body lev­els that might be pro­tec­tive. Sci­en­tists are still try­ing to un­der­stand what role these kinds of an­ti­bod­ies play in pro­tec­tion from fu­ture virus ex­po­sures.

Of­fi­cials con­tin­ue to urge Amer­i­cans to get vac­cines and boost­ers, which of­fer ad­di­tion­al pro­tec­tion against COVID-19 for all, in­clud­ing those who were pre­vi­ous­ly in­fect­ed.

Cur­rent­ly the U.S. of­fers a boost­er dose start­ing at age 12 but Pfiz­er and BioN­Tech on Tues­day asked the Food and Drug Ad­min­is­tra­tion to al­low healthy el­e­men­tary-age kids to al­so get one -- about six months af­ter their last shot. The com­pa­nies cit­ed a small study show­ing the ex­tra shot for kids ages 5 to 11 revved up an­ti­bod­ies ca­pa­ble of fight­ing the su­per-con­ta­gious omi­cron vari­ant. Pfiz­er’s kid-size shots are a third of the dose giv­en to any­one 12 or old­er.

AP Med­ical Writer Lau­ran Neer­gaard in Wash­ing­ton con­tributed to this re­port.

 

 

COVID-19COVID-19 casesCDC


Related articles

Sponsored

Weather

PORT OF SPAIN WEATHER

Sponsored